• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Successful resection of localized intestinal lymphangiectasia post-Fontan: role of (99m)technetium-dextran scintigraphy.

作者信息

Connor Frances L, Angelides Socrates, Gibson Miriam, Larden Dale W, Roman Marcin R, Jones Owen, Currie Bruce G, Day Andrew S, Bohane Timothy D

机构信息

Department of Gastroenterology, Sydney Children's Hospital, NSW, Australia.

出版信息

Pediatrics. 2003 Sep;112(3 Pt 1):e242-7. doi: 10.1542/peds.112.3.e242.

DOI:10.1542/peds.112.3.e242
PMID:12949320
Abstract

Intestinal lymphangiectasia is a well-recognized complication of the Fontan procedure, occurring in up to 24% of patients. Because of the loss of chylous fluid into the gut lumen, protein-losing enteropathy results as well as lymphopenia and hypogammaglobulinaemia. In some cases, dilated lymphatics in the intestinal serosa or mesentery also rupture, causing chylous ascites. Standard medical and cardiac surgical interventions are generally ineffective and the condition is frequently lethal. We report a case of intractable and life-threatening chylous ascites and chylothorax in a 14-year-old girl, associated with intestinal lymphangiectasia and protein-losing enteropathy after a Fontan procedure for tricuspid atresia. The condition was refractory to all standard medical therapies, including dietary modifications, diuretics, corticosteroid therapy, albumin infusions, octreotide, heparin, bowel rest, and parenteral nutrition. Cardiac surgery to optimize her hemodynamic status was also ineffective and large volume pleural and ascitic fluid losses continued. Having exhausted all other therapeutic modalities, (99m)technetium-dextran scintigraphy was performed to assess the extent of intestinal protein loss and the potential for surgical intervention. Scintigraphy suggested localized protein loss from the proximal jejunum and subsequent segmental resection was effective. Postoperatively, ascites and pleural effusions resolved, and there was no evidence of short bowel syndrome. Growth has accelerated and the patient has entered puberty. There is mild persistent intestinal protein loss requiring diuretic therapy. Ascites or pleural effusions are absent, and the patient remains well >2 years after surgery. Intestinal lymphangiectasia post-Fontan procedures has traditionally been ascribed to hemodynamic factors such as raised systemic venous pressure, which would predispose to a generalized intestinal lesion. However, in this case, scintigraphy demonstrated a localized, surgically correctible lesion. To our knowledge, this is the first reported case of the use of (99m)technetium-dextran scintigraphy for this indication and of successful partial small bowel resection in such a case.

摘要

相似文献

1
Successful resection of localized intestinal lymphangiectasia post-Fontan: role of (99m)technetium-dextran scintigraphy.
Pediatrics. 2003 Sep;112(3 Pt 1):e242-7. doi: 10.1542/peds.112.3.e242.
2
Intestinal lymphangiectasia: value of Tc-99m dextran lymphoscintigraphy.肠淋巴管扩张症:锝-99m右旋糖酐淋巴闪烁显像的价值
Clin Nucl Med. 1997 Oct;22(10):695-6. doi: 10.1097/00003072-199710000-00007.
3
Scintigraphic diagnosis of protein losing enteropathy using Tc-99m dextran.利用锝-99m标记右旋糖酐对蛋白丢失性肠病进行闪烁扫描诊断。
Clin Nucl Med. 1995 Dec;20(12):1070-3. doi: 10.1097/00003072-199512000-00007.
4
Gastrointestinal haemorrhage due to lymphangiectasia caused by protein-losing enteropathy in the Fontan circulation.在Fontan循环中,由蛋白丢失性肠病引起的淋巴管扩张导致的胃肠道出血。
Cardiol Young. 2017 Oct;27(8):1641-1643. doi: 10.1017/S1047951117000853. Epub 2017 Jun 27.
5
Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy.原发性肠及胸导管扩张症:抗纤溶酶治疗的反应
Pediatrics. 2002 Jun;109(6):1177-80. doi: 10.1542/peds.109.6.1177.
6
Primary intestinal lymphangiectasia (Waldmann's disease).原发性肠淋巴管扩张症(瓦尔德曼病)。
Orphanet J Rare Dis. 2008 Feb 22;3:5. doi: 10.1186/1750-1172-3-5.
7
Clinical Profile, Response to Therapy, and Outcome of Children with Primary Intestinal Lymphangiectasia.原发性肠淋巴管扩张症患儿的临床特征、治疗反应及转归。
Dig Dis. 2019;37(6):458-466. doi: 10.1159/000499450. Epub 2019 Apr 26.
8
Octreotide in the treatment of intestinal lymphangiectasia.奥曲肽治疗肠淋巴管扩张症。
Eur J Gastroenterol Hepatol. 1998 Aug;10(8):699-702.
9
Diagnosing protein losing enteropathy. A new approach using Tc-99m human immunoglobulin.诊断蛋白丢失性肠病。一种使用锝-99m人免疫球蛋白的新方法。
Clin Nucl Med. 1995 Nov;20(11):969-72. doi: 10.1097/00003072-199511000-00004.
10
Location of regional intestinal lymphangiectasia using Tc-99m dextran lymphoscintigraphy.利用锝-99m右旋糖酐淋巴闪烁显像术定位区域性肠淋巴管扩张症
Clin Nucl Med. 1999 Mar;24(3):210-1. doi: 10.1097/00003072-199903000-00025.

引用本文的文献

1
Evaluation of Immune System Components in Dogs With Protein-Losing Enteropathy Compared to Healthy Controls.与健康对照犬相比,蛋白质丢失性肠病犬免疫系统成分的评估。
J Vet Intern Med. 2025 Sep-Oct;39(5):e70245. doi: 10.1111/jvim.70245.
2
Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory data.基于锝-99m白蛋白闪烁扫描术的蛋白丢失性肠病严重程度与患者特征及实验室数据之间的关联。
Ann Nucl Med. 2025 Sep 22. doi: 10.1007/s12149-025-02109-5.
3
Protein losing enteropathy after the Fontan operation.
Fontan手术后的蛋白丢失性肠病。
Int J Cardiol Congenit Heart Dis. 2022 Jan 26;7:100338. doi: 10.1016/j.ijcchd.2022.100338. eCollection 2022 Mar.
4
Lymphopenia in the Adult Population With Fontan Physiology: A Potential New Marker for Disease Assessment.具有Fontan循环生理的成年人群中的淋巴细胞减少:疾病评估的一个潜在新标志物。
CJC Open. 2024 Feb 6;6(6):773-780. doi: 10.1016/j.cjco.2024.01.012. eCollection 2024 Jun.
5
Pathophysiology, Diagnosis, and Management of Canine Intestinal Lymphangiectasia: A Comparative Review.犬肠道淋巴管扩张症的病理生理学、诊断与管理:一项比较性综述
Animals (Basel). 2022 Oct 15;12(20):2791. doi: 10.3390/ani12202791.
6
Intrahepatic Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography: Potential Imaging Signature for Protein-Losing Enteropathy in Congenital Heart Disease.肝内动态对比增强磁共振淋巴造影:先天性心脏病蛋白丢失性肠病的潜在影像学特征。
J Am Heart Assoc. 2021 Oct 5;10(19):e021542. doi: 10.1161/JAHA.121.021542. Epub 2021 Sep 25.
7
Resolution of Protein-Losing Enteropathy after Congenital Heart Disease Repair by Selective Lymphatic Embolization.先天性心脏病修复术后通过选择性淋巴管栓塞治愈蛋白丢失性肠病
Pediatr Gastroenterol Hepatol Nutr. 2019 Nov;22(6):594-600. doi: 10.5223/pghn.2019.22.6.594. Epub 2019 Nov 7.
8
Recent Advances and Trends in Pediatric Cardiac Imaging.儿科心脏成像的最新进展与趋势
Curr Treat Options Cardiovasc Med. 2018 Feb 21;20(1):9. doi: 10.1007/s11936-018-0599-x.
9
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.蛋白丢失性肠病:与临床和亚临床疾病状态的机制关联的全面综述
Clin Exp Gastroenterol. 2017 Jul 17;10:147-168. doi: 10.2147/CEG.S136803. eCollection 2017.
10
The Lymphatic Circulation in Adaptations to the Fontan Circulation.适应Fontan循环过程中的淋巴循环
Pediatr Cardiol. 2017 Jun;38(5):886-892. doi: 10.1007/s00246-017-1576-y. Epub 2017 Feb 16.